← Browse by Condition
Medical Condition
pulmonary regurgitation
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for pulmonary regurgitation sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
NCT04084132
Recruiting
Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation
Enrollment
120 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
NCT06668389 Phase 4
Recruiting
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
Enrollment
106 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
NCT04570163
Recruiting
Berlin Registry of Right Heart Interventions
Enrollment
200 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology